On the public citation graph
The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer
0 signed · 442 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.283.15.2008openalex-snapshot
Meta-analysis of Observational Studies in Epidemiology A Proposal for Reporting
inferredcites →https://doi.org/10.1002/(sici)1097-0142(19980901)83:5<1012::aid-cncr28>3.0.co;2-9openalex-snapshot
Prospective multicenter study of thyroid carcinoma treatment
inferredcites →https://doi.org/10.1002/cncr.22754openalex-snapshot
Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid
inferredcites →https://doi.org/10.1002/cncr.24118openalex-snapshot
High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas
inferredcites →https://doi.org/10.1002/cncr.24416openalex-snapshot
Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005
inferredcites →https://doi.org/10.1002/ijc.22290openalex-snapshot
Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF status
inferredcites →https://doi.org/10.1002/sim.1186openalex-snapshot
Quantifying heterogeneity in a meta‐analysis
inferredcites →https://doi.org/10.1007/bf03346593openalex-snapshot
BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic
inferredcites →https://doi.org/10.1007/s00423-010-0682-6openalex-snapshot
Impact of pathognomonic genetic alterations on the prognosis of papillary thyroid carcinoma
inferredcites →https://doi.org/10.1016/0002-9343(94)90321-2openalex-snapshot
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
inferredcites →https://doi.org/10.1016/j.clon.2010.05.004openalex-snapshot
Thyroid Cancer Epidemiology and Prognostic Variables
inferredcites →https://doi.org/10.1016/j.mce.2009.10.012openalex-snapshot
Prognostic utility of BRAF mutation in papillary thyroid cancer
inferredcites →https://doi.org/10.1016/j.surg.2008.08.034openalex-snapshot
The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma
inferredcites →https://doi.org/10.1016/j.surg.2009.09.011openalex-snapshot
Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation
inferredcites →https://doi.org/10.1016/s0140-6736(09)60731-5openalex-snapshot
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1038/nature00766openalex-snapshot
Mutations of the BRAF gene in human cancer
inferredcites →https://doi.org/10.1038/onc.2011.44openalex-snapshot
Progression of BRAF-induced thyroid cancer is associated with epithelial–mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling
inferredcites →https://doi.org/10.1073/pnas.1004934107openalex-snapshot
B-Raf V600E and thrombospondin-1 promote thyroid cancer progression
inferredcites →https://doi.org/10.1080/00313020600696264openalex-snapshot
BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas
inferredcites →https://doi.org/10.1089/thy.2010.0174openalex-snapshot
Molecular, Morphologic, and Outcome Analysis of Thyroid Carcinomas According to Degree of Extrathyroid Extension
inferredcites →https://doi.org/10.1093/jnci/95.8.625openalex-snapshot
BRAF Mutation in Papillary Thyroid Carcinoma
inferredcites →https://doi.org/10.1097/01.pas.0000176432.73455.1bopenalex-snapshot
Correlation Between Genetic Alterations and Microscopic Features, Clinical Manifestations, and Prognostic Characteristics of Thyroid Papillary Carcinomas
inferredcites →https://doi.org/10.1097/01.sla.0000224751.80858.13openalex-snapshot
Lymphatic Mapping Establishes the Role of BRAF Gene Mutation in Papillary Thyroid Carcinoma
inferredcites →https://doi.org/10.1097/sla.0b013e318148563dopenalex-snapshot
The Prevalence and Prognostic Value of BRAF Mutation in Thyroid Cancer
inferredcites →https://doi.org/10.1111/j.1365-2265.2004.02089.xopenalex-snapshot
BRAF mutations in an Italian cohort of thyroid cancers
inferredcites →https://doi.org/10.1111/j.1365-2265.2005.02367.xopenalex-snapshot
No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan
inferredcites →https://doi.org/10.1111/j.1365-2265.2005.02389.xopenalex-snapshot
The BRAFV600E mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma
inferredcites →https://doi.org/10.1111/j.1440-1827.2005.01866.xopenalex-snapshot
Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto's thyroiditis
inferredcites →https://doi.org/10.1136/bmj.327.7414.557openalex-snapshot
Measuring inconsistency in meta-analyses
inferredcites →https://doi.org/10.1158/0008-5472.can-10-3844openalex-snapshot
BRAFV600E and Microenvironment in Thyroid Cancer: A Functional Link to Drive Cancer Progression
inferredcites →https://doi.org/10.1210/er.2007-0007openalex-snapshot
BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications
inferredcites →https://doi.org/10.1210/jc.2003-030305openalex-snapshot
Clinical Implication of Hot SpotBRAFMutation, V599E, in Papillary Thyroid Cancers
inferredcites →https://doi.org/10.1210/jc.2005-0285openalex-snapshot
Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis
inferredcites →https://doi.org/10.1210/jc.2005-0987openalex-snapshot
BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer
inferredcites →https://doi.org/10.1210/jc.2005-2836openalex-snapshot
Influence of the BRAF V600E Mutation on Expression of Vascular Endothelial Growth Factor in Papillary Thyroid Cancer
inferredcites →https://doi.org/10.1210/jc.2006-2707openalex-snapshot
BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism
inferredcites →https://doi.org/10.1210/jc.2007-1179openalex-snapshot
Association of BRAF V600E Mutation with Poor Clinicopathological Outcomes in 500 Consecutive Cases of Papillary Thyroid Carcinoma
inferredcites →https://doi.org/10.1210/jc.2007-1717openalex-snapshot
Clinicopathological Analysis of Papillary Thyroid Cancer withPIK3CAAlterations in a Middle Eastern Population
inferredcites →https://doi.org/10.1210/jc.2008-0607openalex-snapshot
BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
inferredcites →https://doi.org/10.1210/jc.2008-2390openalex-snapshot
Association of High Iodine Intake with the T1799A BRAF Mutation in Papillary Thyroid Cancer
inferredcites →https://doi.org/10.1210/jc.82.11.3553openalex-snapshot
Pathological Tumor-Node-Metastasis (pTNM) Staging for Papillary and Follicular Thyroid Carcinomas: A Retrospective Analysis of 700 Patients
inferredcites →https://doi.org/10.1507/endocrj.k08e-208openalex-snapshot
BRAF Mutation in Papillary Thyroid Carcinoma in a Japanese Population: Its Lack of Correlation with High-Risk Clinicopathological Features and Disease-Free Survival of Patients
inferredcites →https://doi.org/10.1507/endocrj.k08e-335openalex-snapshot
[Comments on the Ito et al. article (Endocr J. 2008 Oct 8. Epub ahead of print)] The Lack of Clinicopathological Correlation of BRAF Mutation in Papillary Thyroid Cancer Needs to Be Interpreted with Caution
inferredcites →https://doi.org/10.1634/theoncologist.2010-0317openalex-snapshot
Targeting BRAFV600E with PLX4720 Displays Potent Antimigratory and Anti-invasive Activity in Preclinical Models of Human Thyroid Cancer
inferredcites →https://doi.org/10.1677/erc-07-0182openalex-snapshot
Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer
inferredcites →https://doi.org/10.1677/erc-07-0212openalex-snapshot
BRAF(V600E) mutation and the biology of papillary thyroid cancer
inferredcites →https://doi.org/10.1677/erc.1.01119openalex-snapshot
The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4679715openalex-extracted
Polychlorinated Biphenyl Concentrations in Serum from Patients with and Without Thyroid Cancer and Associations with the Brafv600e Mutation
inferred← citeshttps://doi.org/10.1001/jama.2013.3190openalex-snapshot
Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
inferred← citeshttps://doi.org/10.1001/jama.2013.8598openalex-snapshot
BRAFV600E Mutation and Papillary Thyroid Cancer—In Reply
inferred← citeshttps://doi.org/10.1001/jamaoncol.2020.5935openalex-snapshot
Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules
inferred← citeshttps://doi.org/10.1001/jamaoto.2013.4501openalex-snapshot
Lack of Association ofBRAFMutation With Negative Prognostic Indicators in Papillary Thyroid Carcinoma
inferred← citeshttps://doi.org/10.1001/jamasurg.2016.0825openalex-snapshot
Molecular-Directed Treatment of Differentiated Thyroid Cancer
inferred← citeshttps://doi.org/10.1002/1878-0261.13396openalex-snapshot
Overexpression of the pro‐protein convertase furin predicts prognosis and promotes papillary thyroid carcinoma progression and metastasis through RAF / MEK signaling
inferred← citeshttps://doi.org/10.1002/9781118468678.ch31openalex-snapshot
RAS‐RAF‐MEK Pathway: Aberrations and Therapeutic Possibilities
inferred← citeshttps://doi.org/10.1002/biof.1561openalex-snapshot
Bioinformatic analysis of the prognostic value and potential regulatory network of FOXF1 in papillary thyroid cancer
inferred← citeshttps://doi.org/10.1002/cam4.417openalex-snapshot
BRAF mutation is not predictive of long‐term outcome in papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.5349openalex-snapshot
Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study
inferred← citeshttps://doi.org/10.1002/cncr.27888openalex-snapshot
Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules
inferred← citeshttps://doi.org/10.1002/cncr.28526openalex-snapshot
Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: A prospective case series of 960 patients
inferred← citeshttps://doi.org/10.1002/cncy.21352openalex-snapshot
Value of immunohistochemistry in the detection of BRAFV600E mutations in fine‐needle aspiration biopsies of papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1002/cncy.21416openalex-snapshot
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience
inferred← citeshttps://doi.org/10.1002/cncy.21475openalex-snapshot
Morphological parameters able to predict BRAFV600E ‐mutated malignancies on thyroid fine‐needle aspiration cytology: Our institutional experience
inferred← citeshttps://doi.org/10.1002/cncy.21586openalex-snapshot
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights
inferred← citeshttps://doi.org/10.1002/cncy.22746openalex-snapshot
Single BRAFV600E mutation is not associated with aggressive biological behavior in adolescent and pediatric papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1002/dc.24963openalex-snapshot
Diagnostic strategy of fine needle aspiration cytology of cystic cervical lymph node metastasis from papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1002/dc.25035openalex-snapshot
Molecular testing in fine‐needle aspiration of thyroid nodules
inferred← citeshttps://doi.org/10.1002/hed.23770openalex-snapshot
BRAF mutation in fine‐needle aspiration specimens as a potential predictor for persistence/recurrence in patients with classical papillary thyroid carcinoma larger than 10 mm at a BRAF mutation prevalent area
inferred← citeshttps://doi.org/10.1002/hed.23854openalex-snapshot
Combined effect of Hashimoto's thyroiditis and BRAFV600E mutation status on aggressiveness in papillary thyroid cancer
inferred← citeshttps://doi.org/10.1002/hed.24149openalex-snapshot
Potential relationship between Hashimoto's thyroiditis and BRAFV600E mutation status in papillary thyroid cancer
inferred← citeshttps://doi.org/10.1002/hed.24466openalex-snapshot
Prognostic role of the Bethesda System for conventional papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1002/hed.24715openalex-snapshot
Indications and extent of central neck dissection for papillary thyroid cancer: An American Head and Neck Society Consensus Statement
inferred← citeshttps://doi.org/10.1002/hed.24807openalex-snapshot
Structural alterations in tumor‐draining lymph nodes before papillary thyroid carcinoma metastasis
inferred← citeshttps://doi.org/10.1002/hed.25105openalex-snapshot
Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2‐Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1002/ijc.28976openalex-snapshot
Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1002/jcb.28374openalex-snapshot
Retracted : microRNA‐539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor
inferred← citeshttps://doi.org/10.1002/jso.23734openalex-snapshot
Genomic medicine for cancer prognosis
inferred← citeshttps://doi.org/10.1002/jso.24129openalex-snapshot
Molecular targeting of papillary thyroid carcinoma with fluorescently labeled ratiometric activatable cell penetrating peptides in a transgenic murine model
inferred← citeshttps://doi.org/10.1002/jso.24673openalex-snapshot
Surgical considerations for papillary thyroid microcarcinomas
inferred← citeshttps://doi.org/10.1002/jum.15967openalex-snapshot
Targeting Diagnosis of High‐Risk Papillary Thyroid Carcinoma Using Ultrasound Contrast Agent With the BRAFV600E Mutation
inferred← citeshttps://doi.org/10.1002/lary.23838openalex-snapshot
Diagnosis and management of differentiated thyroid cancer using molecular biology
inferred← citeshttps://doi.org/10.1007/978-1-4939-1578-1_16openalex-snapshot
Thyroid, Parathyroid and Adrenal Glands
inferred← citeshttps://doi.org/10.1007/978-1-4939-3314-3_22openalex-snapshot
Diagnostic and Prognostic Molecular Markers in Thyroid Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-61919-0_4openalex-snapshot
A Patient with Papillary Microcarcinoma Undergoing Active Surveillance
inferred← citeshttps://doi.org/10.1007/978-3-030-73951-5_2openalex-snapshot
Molecular Assessment of Thyroid Nodules
inferred← citeshttps://doi.org/10.1007/978-3-030-83328-2_17openalex-snapshot
Thyroid, Parathyroid, and Adrenal Glands
inferred← citeshttps://doi.org/10.1007/978-3-030-84432-5_6openalex-snapshot
Biomarkers in Endocrine Organ Carcinomas
inferred← citeshttps://doi.org/10.1007/978-3-319-22401-5_3openalex-snapshot
The Decision-Making Process for Prophylactic Central Neck Dissection in a Patient Presenting with an Indeterminate Thyroid Nodule on Cytology Assessment: Role of Preoperative Ultrasound and Molecular Marker Testing
inferred← citeshttps://doi.org/10.1007/978-3-319-43618-0_11openalex-snapshot
Staging for Papillary Thyroid Cancer
inferred← citeshttps://doi.org/10.1007/978-81-322-2434-1_1openalex-snapshot
Molecular Risk Stratification of Well-Differentiated Thyroid Cancer
inferred← citeshttps://doi.org/10.1007/978-981-13-1897-9_60openalex-snapshot
Thyroid Fine-Needle Aspiration Cytology Molecular Testing in the USA
inferred← citeshttps://doi.org/10.1007/s00268-013-2223-2openalex-snapshot
BRAFV600E Mutation Analysis in Papillary Thyroid Carcinoma: Is it Useful for all Patients?
inferred← citeshttps://doi.org/10.1007/s00268-016-3534-xopenalex-snapshot
BRAFV600E Mutation is Associated with Decreased Disease‐Free Survival in Papillary Thyroid Cancer
inferred← citeshttps://doi.org/10.1007/s00405-013-2872-7openalex-snapshot
The association between BRAF V600E mutation and pathological features in PTC
inferred← citeshttps://doi.org/10.1007/s00405-018-4944-1openalex-snapshot
Molecular markers in well-differentiated thyroid cancer
inferred← citeshttps://doi.org/10.1007/s00423-012-0918-8openalex-snapshot
Lynch syndrome: clinical, pathological, and genetic insights
inferred← citeshttps://doi.org/10.1007/s00428-013-1521-2openalex-snapshot
Prognostic biomarkers in thyroid cancer
inferred← citeshttps://doi.org/10.1007/s00428-014-1552-3openalex-snapshot
Morphology predicts BRAF V600E mutation in papillary thyroid carcinoma: an interobserver reproducibility study
inferred← citeshttps://doi.org/10.1007/s00428-021-03137-yopenalex-snapshot
Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1007/s10014-019-00347-wopenalex-snapshot
A long-term survivor of pediatric midline glioma with H3F3A K27M and BRAF V600E double mutations
inferred← citeshttps://doi.org/10.1007/s10147-026-03129-5openalex-snapshot
Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis
inferred← citeshttps://doi.org/10.1007/s11060-014-1450-1openalex-snapshot
Pediatric posterior fossa ganglioglioma: unique MRI features and correlation with BRAF V600E mutation status
inferred← citeshttps://doi.org/10.1007/s11596-015-1476-4openalex-snapshot
BRAFV600E mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis
inferred← citeshttps://doi.org/10.1007/s11596-018-1945-7openalex-snapshot
Predictive Value of BRAFV600E Mutation for Lymph Node Metastasis in Papillary Thyroid Cancer: A Meta-analysis
inferred← citeshttps://doi.org/10.1007/s11864-011-0175-zopenalex-snapshot
Extent of Surgery for Papillary Thyroid Cancer: Preoperative Imaging and Role of Prophylactic and Therapeutic Neck Dissection
inferred← citeshttps://doi.org/10.1007/s11864-016-0404-6openalex-snapshot
Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer
inferred← citeshttps://doi.org/10.1007/s12020-012-9651-xopenalex-snapshot
BRAFV600E mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness
inferred← citeshttps://doi.org/10.1007/s12020-012-9806-9openalex-snapshot
Pituitary metastasis of thyroid cancer
inferred← citeshttps://doi.org/10.1007/s12020-013-0029-5openalex-snapshot
The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis
inferred← citeshttps://doi.org/10.1007/s12020-014-0222-1openalex-snapshot
Thyroid fine-needle aspiration: the relevance of BRAF mutation testing
inferred← citeshttps://doi.org/10.1007/s12020-015-0592-zopenalex-snapshot
Somatic amplifications and deletions in genome of papillary thyroid carcinomas
inferred← citeshttps://doi.org/10.1007/s12020-016-0866-0openalex-snapshot
The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms
inferred← citeshttps://doi.org/10.1007/s12020-016-1044-0openalex-snapshot
The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation
inferred← citeshttps://doi.org/10.1007/s12020-017-1340-3openalex-snapshot
Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer
inferred← citeshttps://doi.org/10.1007/s12020-022-03126-4openalex-snapshot
Diagnostic and prognostic value of Stanniocalcin 1 expression in papillary thyroid cancer
inferred← citeshttps://doi.org/10.1007/s12020-023-03350-6openalex-snapshot
TESC promotes differentiated thyroid cancer development by activating ERK and weakening NIS and radioiodine uptake
inferred← citeshttps://doi.org/10.1007/s12022-012-9218-7openalex-snapshot
The Relationship of the BRAFV600E Mutation and the Established Prognostic Factors in Papillary Thyroid Carcinomas
inferred← citeshttps://doi.org/10.1007/s12022-016-9420-0openalex-snapshot
Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF V600E Harboring Pediatric Papillary Thyroid Carcinomas
inferred← citeshttps://doi.org/10.1007/s12022-017-9476-5openalex-snapshot
The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas
inferred← citeshttps://doi.org/10.1007/s12022-019-09591-4openalex-snapshot
The Role of BRAF V600E in Reducing AUS/FLUS Diagnosis in Thyroid Fine Needle Aspiration
inferred← citeshttps://doi.org/10.1007/s12022-023-09778-wopenalex-snapshot
Incidence and Clinicopathological Features of Differentiated High-Grade Thyroid Carcinomas: An Institutional Experience
inferred← citeshttps://doi.org/10.1007/s12022-025-09859-yopenalex-snapshot
Prevalence and Clinical Impact of BRAF p.V600E Mutation in Papillary Thyroid Carcinoma
inferred← citeshttps://doi.org/10.1007/s12672-025-04090-xopenalex-snapshot
Relationship between the BRAF-V600E variant allele frequency and clinicopathological characteristics of papillary thyroid carcinoma and its clinical application
inferred← citeshttps://doi.org/10.1007/s13277-014-1865-5openalex-snapshot
Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis
inferred← citeshttps://doi.org/10.1007/s40618-015-0376-6openalex-snapshot
Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1016/b978-0-323-66127-0.00019-3openalex-snapshot
Papillary Thyroid Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-323-71257-6.00028-9openalex-snapshot
Neoplasms of the Thyroid Gland
inferred← citeshttps://doi.org/10.1016/j.aforl.2013.05.003openalex-snapshot
La mutation BRAF dans le carcinome papillaire de la thyroïde : intérêt dans le pronostic à long terme et dans l’iodosensibilité
inferred← citeshttps://doi.org/10.1016/j.amjsurg.2017.12.006openalex-snapshot
High suspicion US pattern on the ATA guidelines, not cytologic diagnosis, may be a predicting marker of lymph node metastasis in patients with classical papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1016/j.anorl.2013.01.004openalex-snapshot
BRAF mutation in papillary thyroid carcinoma: Predictive value for long-term prognosis and radioiodine sensitivity
inferred← citeshttps://doi.org/10.1016/j.asjsur.2023.09.049openalex-snapshot
BRAF V600E mutation co-existing with oncogenic mutations is associated with aggressive clinicopathologic features and poor prognosis in papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1016/j.bcmd.2014.01.001openalex-snapshot
BRAF — A new player in hematological neoplasms
inferred← citeshttps://doi.org/10.1016/j.biopha.2018.05.078openalex-snapshot
RETRACTED: Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor
inferred← citeshttps://doi.org/10.1016/j.bjorl.2020.07.007openalex-snapshot
Characterization of BRAF mutation in patients older than 45 years with well-differentiated thyroid carcinoma
inferred← citeshttps://doi.org/10.1016/j.bjorlp.2022.04.004openalex-snapshot
10.1016/j.bjorlp.2022.04.004
inferred← citeshttps://doi.org/10.1016/j.cca.2026.121178openalex-snapshot
Molecular Landscape and Advanced Diagnostic Technologies for BRAF Mutations in Cancer: From Quantitative PCR and ddPCR to CRISPR-Based Platforms
inferred← citeshttps://doi.org/10.1016/j.cireng.2018.05.010openalex-snapshot
BRAF V600E Mutation in Papillary Thyroid Cancer and Its Effect on Postoperative Radioiodine (131I) Therapy: Should We Modify Our Therapeutic Strategy?
inferred← citeshttps://doi.org/10.1016/j.ciresp.2018.02.018openalex-snapshot
Mutación del gen BRAF V600E en el cáncer papilar de tiroides y su efecto en la terapia con yodo radiactivo ( 131 I) posquirúrgica: ¿deberíamos modificar nuestra estrategia terapéutica?
inferred← citeshttps://doi.org/10.1016/j.clon.2012.01.001openalex-snapshot
Iodine or Not (IoN) for Low-risk Differentiated Thyroid Cancer: The Next UK National Cancer Research Network Randomised Trial following HiLo
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2013.12.008openalex-snapshot
BRAF inhibitors: From the laboratory to clinical trials
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2022.103707openalex-snapshot
Tissue and circulating PD-L2: moving from health and immune-mediated diseases to head and neck oncology
inferred← citeshttps://doi.org/10.1016/j.ecl.2014.02.015openalex-snapshot
Molecular Diagnostics for Thyroid Nodules
inferred← citeshttps://doi.org/10.1016/j.ejso.2020.05.027openalex-snapshot
Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation
inferred← citeshttps://doi.org/10.1016/j.endonu.2015.02.006openalex-snapshot
Guía clínica para el manejo de pacientes con carcinoma diferenciado de tiroides de bajo riesgo
inferred← citeshttps://doi.org/10.1016/j.eprac.2024.05.016openalex-snapshot
Thyroid Nodules: Past, Present, and Future
inferred← citeshttps://doi.org/10.1016/j.eprac.2025.12.003openalex-snapshot
Prognostic Value of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis of Nodal Involvement, Distant Metastases, Recurrence, and Mortality
inferred← citeshttps://doi.org/10.1016/j.humpath.2016.03.013openalex-snapshot
Use of monoclonal antibodies to detect specific mutations in formalin-fixed, paraffin-embedded tissue sections
inferred← citeshttps://doi.org/10.1016/j.jcma.2014.09.010openalex-snapshot
A systematic review of genetic studies of thyroid disorders in Taiwan
inferred← citeshttps://doi.org/10.1016/j.jcte.2025.100390openalex-snapshot
Prediction of BRAF and TERT status in PTCs by machine learning-based ultrasound radiomics methods: A multicenter study
inferred← citeshttps://doi.org/10.1016/j.jmoldx.2015.08.003openalex-snapshot
Detection of Circulating BRAF in Patients with Papillary Thyroid Carcinoma
inferred← citeshttps://doi.org/10.1016/j.jss.2012.08.053openalex-snapshot
Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing
inferred← citeshttps://doi.org/10.1016/j.lfs.2023.121938openalex-snapshot
Identification of Serpin peptidase inhibitor clade A member 1 (SERPINA1) might be a poor prognosis biomarker promoting the progression of papillary thyroid cancer
inferred← citeshttps://doi.org/10.1016/j.mce.2013.07.030openalex-snapshot
Genetics and epigenetics of sporadic thyroid cancer
inferred← citeshttps://doi.org/10.1016/j.mce.2023.112113openalex-snapshot
The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia
inferred← citeshttps://doi.org/10.1016/j.medcle.2016.06.014openalex-snapshot
New therapies in thyroid cancer
inferred← citeshttps://doi.org/10.1016/j.medcli.2015.11.012openalex-snapshot
Nuevas terapias en el cáncer de tiroides
inferred← citeshttps://doi.org/10.1016/j.modpat.2023.100242openalex-snapshot
A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases
inferred← citeshttps://doi.org/10.1016/j.oraloncology.2024.106755openalex-snapshot
BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients
inferred← citeshttps://doi.org/10.1016/j.oraloncology.2025.107464openalex-snapshot
RET fusion rather than BRAF mutation confers a higher risk of aggressiveness and recurrence in papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1016/j.otc.2014.04.010openalex-snapshot
The Prognostic Implications from Molecular Testing of Thyroid Cancer
inferred← citeshttps://doi.org/10.1016/j.path.2019.08.002openalex-snapshot
Molecular Alterations in Thyroid Carcinoma
inferred← citeshttps://doi.org/10.1016/j.semcdb.2015.10.001openalex-snapshot
Regulation of the ErbB network by the MIG6 feedback loop in physiology, tumor suppression and responses to oncogene-targeted therapeutics
inferred← citeshttps://doi.org/10.1016/j.suc.2019.04.002openalex-snapshot
Decision Making in Indeterminate Thyroid Nodules and the Role of Molecular Testing
inferred← citeshttps://doi.org/10.1016/j.suc.2019.04.004openalex-snapshot
Management of Nodal Disease in Thyroid Cancer
inferred← citeshttps://doi.org/10.1016/j.surg.2013.12.025openalex-snapshot
Clinical significance of the BRAFV600E mutation in multifocal papillary thyroid carcinoma in Korea
inferred← citeshttps://doi.org/10.1016/j.surg.2014.07.015openalex-snapshot
Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer
inferred← citeshttps://doi.org/10.1016/j.suronc.2020.03.008openalex-snapshot
Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer
inferred← citeshttps://doi.org/10.1016/j.tranon.2023.101809openalex-snapshot
TRPC5 expression promotes the proliferation and invasion of papillary thyroid carcinoma through the HIF-1α/Twist pathway
inferred← citeshttps://doi.org/10.1016/j.ultrasmedbio.2015.08.023openalex-snapshot
Diagnostic Efficacy of Ultrasonographic Characteristics of Thyroid Carcinoma in Predicting Cervical Lymph Node Metastasis
inferred← citeshttps://doi.org/10.1016/j.yexmp.2012.05.011openalex-snapshot
DHPLC is a highly sensitive and rapid screening method to detect BRAFV600E mutation in papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1016/s0140-6736(13)60109-9openalex-snapshot
Progress in molecular-based management of differentiated thyroid cancer
inferred← citeshttps://doi.org/10.1016/s2213-8587(14)70051-8openalex-snapshot
Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets
inferred← citeshttps://doi.org/10.1021/acs.analchem.1c02230openalex-snapshot
Endonuclease IV-Regulated DNAzyme Motor for Universal Single-nucleotide Variation Discrimination
inferred← citeshttps://doi.org/10.1038/ncomms15208openalex-snapshot
Senescent tumor cells lead the collective invasion in thyroid cancer
inferred← citeshttps://doi.org/10.1038/nrc3431openalex-snapshot
Molecular pathogenesis and mechanisms of thyroid cancer
inferred← citeshttps://doi.org/10.1038/nrendo.2012.113openalex-snapshot
Successful remnant ablation—what is success?
inferred← citeshttps://doi.org/10.1038/s41598-018-36171-zopenalex-snapshot
Role of ultrasonographic features and quantified BRAFV600E mutation in lymph node metastasis in Chinese patients with papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1038/s41598-021-86611-6openalex-snapshot
The role of the size in thyroid cancer risk stratification
inferred← citeshttps://doi.org/10.1038/s41598-023-39747-6openalex-snapshot
Predicting BRAFV600E mutations in papillary thyroid carcinoma using six machine learning algorithms based on ultrasound elastography
inferred← citeshttps://doi.org/10.1038/s41698-026-01371-8openalex-snapshot
Impact of BRAF, TERT, and novel mutations on the efficacy of lenvatinib for advanced papillary thyroid cancer: A national genomic database analysis
inferred← citeshttps://doi.org/10.1038/srep36990openalex-snapshot
TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis
inferred← citeshttps://doi.org/10.1038/srep41752openalex-snapshot
TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors
inferred← citeshttps://doi.org/10.1055/b-0041-182808openalex-snapshot
33 Central Neck Dissection: Indications and Technique
inferred← citeshttps://doi.org/10.1055/s-0037-1616610openalex-snapshot
Molecular genetic markers for thyroid FNAB
inferred← citeshttps://doi.org/10.1067/j.cpsurg.2013.02.001openalex-snapshot
Advances in management of thyroid cancer
inferred← citeshttps://doi.org/10.1080/17446651.2017.1309278openalex-snapshot
Prognostic indicators for papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1089/ct.2017;29.176-179openalex-snapshot
Meta-Analysis Confirms the Deleterious Effects of Combined BRAF V600E and Telomerase Reverse Transcriptase Promoter Mutations on the Course and Mortality of Papillary Thyroid Carcinoma
inferred← citeshttps://doi.org/10.1089/thy.2012.0329openalex-snapshot
Changes in the Clinicopathological Characteristics and Outcomes of Thyroid Cancer in Korea over the Past Four Decades
inferred← citeshttps://doi.org/10.1089/thy.2012.0585openalex-snapshot
Association Between Expression of X-Linked Inhibitor of Apoptosis Protein and the Clinical Outcome in a BRAF V600E -Prevalent Papillary Thyroid Cancer Population
inferred← citeshttps://doi.org/10.1089/thy.2012.0654openalex-snapshot
Long-Term Prognosis of Differentiated Thyroid Cancer with Lung Metastasis in Korea and Its Prognostic Factors
inferred← citeshttps://doi.org/10.1089/thy.2013.0036openalex-snapshot
Clinicopathologic Implications of the BRAF V600E Mutation in Papillary Thyroid Cancer: A Subgroup Analysis of 3130 Cases in a Single Center
inferred← citeshttps://doi.org/10.1089/thy.2013.0279openalex-snapshot
Ultrasound-Guided Percutaneous Laser Ablation of Papillary Thyroid Microcarcinoma: A Feasibility Study on Three Cases with Pathological and Immunohistochemical Evaluation
inferred← citeshttps://doi.org/10.1089/thy.2013.0302openalex-snapshot
Diagnostic Value of Immunohistochemistry for the Detection of the BRAF V600E Mutation in Papillary Thyroid Carcinoma: Comparative Analysis with Three DNA-Based Assays
inferred← citeshttps://doi.org/10.1089/thy.2013.0675openalex-snapshot
The BRAF V600E Mutation Influences the Short- and Medium-Term Outcomes of Classic Papillary Thyroid Cancer, But Is Not an Independent Predictor of Unfavorable Outcome
inferred← citeshttps://doi.org/10.1089/thy.2014.0098openalex-snapshot
Management of Recurrent/Persistent Nodal Disease in Patients with Differentiated Thyroid Cancer: A Critical Review of the Risks and Benefits of Surgical Intervention Versus Active Surveillance
inferred← citeshttps://doi.org/10.1089/thy.2014.0123openalex-snapshot
BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF -Mutant Thyroid Cancer
inferred← citeshttps://doi.org/10.1089/thy.2014.0241openalex-snapshot
Prognostic Value of Genetic Mutations in Thyroid Cancer: A Meta-Analysis
inferred← citeshttps://doi.org/10.1089/thy.2015.0020openalex-snapshot
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
inferred← citeshttps://doi.org/10.1089/thy.2015.0079openalex-snapshot
Negative Expression of CPSF2 Predicts a Poorer Clinical Outcome in Patients with Papillary Thyroid Carcinoma
inferred← citeshttps://doi.org/10.1089/thy.2015.0488openalex-snapshot
Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF V600E Mutation–Prevalent Population
inferred← citeshttps://doi.org/10.1089/thy.2015.0665openalex-snapshot
Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters
inferred← citeshttps://doi.org/10.1089/thy.2016.0350openalex-snapshot
Effects of Coexistent BRAF V600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis
inferred← citeshttps://doi.org/10.1089/thy.2016.0387openalex-snapshot
Fusion Oncogenes Are the Main Genetic Events Found in Sporadic Papillary Thyroid Carcinomas from Children
inferred← citeshttps://doi.org/10.1089/thy.2017.0248openalex-snapshot
The Hobnail Variant of Papillary Thyroid Carcinoma: Clinical/Molecular Characteristics of a Large Monocentric Series and Comparison with Conventional Histotypes
inferred← citeshttps://doi.org/10.1089/thy.2017.0322openalex-snapshot
Circulating BRAF V600E Levels Correlate with Treatment in Patients with Thyroid Carcinoma
inferred← citeshttps://doi.org/10.1089/thy.2019.0143openalex-snapshot
Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol
inferred← citeshttps://doi.org/10.1089/thy.2021.0267openalex-snapshot
Circulating Tumor DNA Harboring the BRAF V600E Mutation May Predict Poor Outcomes of Primary Papillary Thyroid Cancer Patients
inferred← citeshttps://doi.org/10.1093/ajcp/aqaa213openalex-snapshot
Prognostic Assessment of BRAF Mutation in Preoperative Thyroid Fine-Needle Aspiration Specimens
inferred← citeshttps://doi.org/10.1093/jnci/djx227openalex-snapshot
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment
inferred← citeshttps://doi.org/10.1097/cco.0000000000000040openalex-snapshot
How to use molecular testing results to guide surgery
inferred← citeshttps://doi.org/10.1097/md.0000000000001246openalex-snapshot
Replication and Meta-Analysis of Common Gene Mutations in TTF1 and TTF2 with Papillary Thyroid Cancer
inferred← citeshttps://doi.org/10.1097/md.0000000000004292openalex-snapshot
The thyroid imaging reporting and data system on US, but not the BRAFV600E mutation in fine-needle aspirates, is associated with lateral lymph node metastasis in PTC
inferred← citeshttps://doi.org/10.1097/md.0000000000005067openalex-snapshot
Is papillary thyroid microcarcinoma an indolent tumor?
inferred← citeshttps://doi.org/10.1097/md.0000000000018917openalex-snapshot
A meta-analysis evaluating the relationship between B-type Raf kinase mutation and cervical lymphatic metastasis in papillary thyroid cancer
inferred← citeshttps://doi.org/10.1097/md.0000000000035960openalex-snapshot
Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules
inferred← citeshttps://doi.org/10.1097/md.0b013e31826a9c71openalex-snapshot
BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment
inferred← citeshttps://doi.org/10.1097/pap.0000000000000113openalex-snapshot
BRAF and Epithelial-Mesenchymal Transition: Lessons From Papillary Thyroid Carcinoma and Primary Cutaneous Melanoma
inferred← citeshttps://doi.org/10.1097/pas.0000000000000304openalex-snapshot
Activating BRAF V600E Mutation in Aggressive Pediatric Langerhans Cell Histiocytosis
inferred← citeshttps://doi.org/10.1097/pas.0000000000000325openalex-snapshot
Comparison of Next-generation Sequencing Mutation Profiling With BRAF and IDH1 Mutation-specific Immunohistochemistry
inferred← citeshttps://doi.org/10.1097/pat.0000000000000008openalex-snapshot
The prognostic significance of the BRAFV600E mutation in papillary thyroid carcinoma detected by mutation-specific immunohistochemistry
inferred← citeshttps://doi.org/10.1097/pat.0b013e328360b61dopenalex-snapshot
Clinicopathological relevance of BRAF mutations in human cancer
inferred← citeshttps://doi.org/10.1097/pcr.0000000000000089openalex-snapshot
Utilization of Molecular Testing in Thyroid Cytology
inferred← citeshttps://doi.org/10.1097/rlu.0000000000000498openalex-snapshot
BRAFV600E Mutation Associated With Non–Radioiodine-Avid Status in Distant Metastatic Papillary Thyroid Carcinoma
inferred← citeshttps://doi.org/10.1097/rlu.0000000000002142openalex-snapshot
BRAFV600E Mutation Does Not Significantly Affect the Efficacy of Radioiodine Therapy in Patients With Papillary Thyroid Carcinoma Without Known Distant Metastases
inferred← citeshttps://doi.org/10.1097/ruq.0000000000000406openalex-snapshot
The Association Among Quantitative Contrast-Enhanced Ultrasonography Features, Thyroid Imaging Reporting and Data System and BRAF V600E Mutation Status in Patients With Papillary Thyroid Microcarcinoma
inferred← citeshttps://doi.org/10.1101/2020.10.31.20223610openalex-snapshot
The ratio of BRAFV600E alleles can be used to assess the biological behavior of papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.11106/cet.2014.7.2.118openalex-snapshot
Gene Methylation Associated with Differentiated Thyroid Cancer
inferred← citeshttps://doi.org/10.11106/ijt.2016.9.2.59openalex-snapshot
2016 Revised Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Thyroid Cancer
inferred← citeshttps://doi.org/10.11106/ijt.2023.16.1.89openalex-snapshot
Thyroid Cancer, Iodine, and Gene Mutation
inferred← citeshttps://doi.org/10.11106/ijt.2025.18.2.119openalex-snapshot
Signal Transduction in Thyrocyte
inferred← citeshttps://doi.org/10.1111/ans.16652openalex-snapshot
Predicting distant metastatic disease in differentiated thyroid cancer: a matched case–control study
inferred← citeshttps://doi.org/10.1111/bjd.12694openalex-snapshot
Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009
inferred← citeshttps://doi.org/10.1111/cen.12386openalex-snapshot
The BRAFV 600E mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?
inferred← citeshttps://doi.org/10.1111/cen.12433openalex-snapshot
BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography
inferred← citeshttps://doi.org/10.1111/cen.12878openalex-snapshot
Concomitant high expression of BRAFV 600E, P‐cadherin and cadherin 6 is associated with High TNM stage and lymph node metastasis in conventional papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1111/cen.13413openalex-snapshot
Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma—A meta‐analysis
inferred← citeshttps://doi.org/10.1111/cen.13506openalex-snapshot
Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre‐operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre
inferred← citeshttps://doi.org/10.1111/coa.12843openalex-snapshot
The utility of intra‐operative frozen section for the evaluation of microscopic extrathyroidal extension in papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1111/coa.13859openalex-snapshot
Association of Bethesda category and molecular mutation in patients undergoing thyroidectomy
inferred← citeshttps://doi.org/10.1111/cyt.12199openalex-snapshot
Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples
inferred← citeshttps://doi.org/10.1111/cyt.12350openalex-snapshot
Morphological features that can predictBRAFV600E‐mutated carcinoma in paediatric thyroid cytology
inferred← citeshttps://doi.org/10.1111/cyt.12555openalex-snapshot
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules
inferred← citeshttps://doi.org/10.1111/his.13401openalex-snapshot
Molecular genotyping of the non‐invasive encapsulated follicular variant of papillary thyroid carcinoma
inferred← citeshttps://doi.org/10.1111/imj.12476openalex-snapshot
Mutation profile of differentiated thyroid tumours in an A ustralian urban population
inferred← citeshttps://doi.org/10.1111/j.1349-7006.2011.02161.xopenalex-snapshot
Notch1 receptor as a marker of lymph node metastases in papillary thyroid cancer
inferred← citeshttps://doi.org/10.1136/jclinpath-2020-207357openalex-snapshot
Cancer-associated fibroblasts (CAFs) in thyroid papillary carcinoma: molecular networks and interactions
showing the first 200 of 395 · page through all 395
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.